Suchergebnisse - "Ovarian Neoplasms/therapy"

Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE: guidelines from ESGO, ESHRE, and ESGE

Autoren: Morice, Philippe Scambia, Giovanni Abu-Rustum, Nadeem R et al.

Weitere Verfasser: Morice, Philippe Scambia, Giovanni Abu-Rustum, Nadeem R et al.

Quelle: The Lancet Oncology. 25:e602-e610

Schlagwörter: fertility, Ovarian Neoplasms, Fertility Preservation, Uterine Cervical Neoplasms, fertility spating, Ovarian Neoplasms/therapy, Fertility, Fertility Preservation/methods, Infertility, Female/etiology, Humans, Female, Infertility, Female, Uterine Cervical Neoplasms/therapy, Systematic Reviews as Topic

Dateibeschreibung: text

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39216500
https://pergamos.lib.uoa.gr/uoa/dl/object/3491440
https://biblio.vub.ac.be/vubir/(37c17e9d-b181-474a-a2c5-8899e849982c).html

Ovarian cancer management in an ESGO ovarian cancer center of excellence: a systematic case study of the interprofessional and interdisciplinary interaction

Autoren: David J. Krankenberg Mustafa Zelal Muallem Klaus Pietzner et al.

Quelle: Arch Gynecol Obstet

Schlagwörter: Male, Ovarian Neoplasms, Patient Care Team, Interprofessional Relations, Cytoreduction Surgical Procedures, Gynecologic Oncology, Middle Aged, Medical Oncology, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Female, Interdisciplinary Communication, Female [MeSH], Medical Oncology [MeSH], Multidisciplinary, Humans [MeSH], Contacts, Patient tracking, Middle Aged [MeSH], Quality Indicators, Health Care [MeSH], Quality indicators, Cytoreduction Surgical Procedures [MeSH], Ovarian Neoplasms/therapy [MeSH], Holistic, Patient Care Team [MeSH], Male [MeSH], Interprofessional Relations [MeSH], Interdisciplinary Communication [MeSH], Quality Indicators, Health Care

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38507090
https://repository.publisso.de/resource/frl:6521437

Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial

Autoren: Maurer, Tabea Belau, M. H. Zyriax, B-C. et al.

Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)

Schlagwörter: Adult, Ovarian Neoplasms, Malnutrition, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Muscle wasting, ddc, Exercise Therapy, Study Protocol, 03 medical and health sciences, Female [MeSH], Malnutrition/etiology [MeSH], Nutrition, Aged [MeSH], Randomized controlled trial, Adult [MeSH], Ovarian cancer, Humans [MeSH], Ovarian Neoplasms/drug therapy [MeSH], Exercise Therapy/methods [MeSH], Middle Aged [MeSH], Multicenter Studies as Topic [MeSH], Ovarian Neoplasms/therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Exercise, Malnutrition/prevention, Quality of Life [MeSH], Exercise [MeSH], 0302 clinical medicine, Quality of Life, Humans, Multicenter Studies as Topic, Female, RC254-282, Aged, Randomized Controlled Trials as Topic

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39528997
https://doaj.org/article/72e6df8646f44d9e9313a94c08ddffbb
https://repository.publisso.de/resource/frl:6505092
https://mediatum.ub.tum.de/doc/1770503/document.pdf

Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects

Autoren: Gerrit Wolters-Eisfeld Leticia Oliveira-Ferrer

Quelle: Semin Immunopathol

Schlagwörter: Ovarian Neoplasms, Glycosylation, Polysaccharides, Tumor Microenvironment, Female [MeSH], Glycan diversity, Glycosylation [MeSH], Ovarian Neoplasms/immunology [MeSH], Ovarian cancer, Humans [MeSH], Animals [MeSH], Disease Susceptibility [MeSH], Tumor Microenvironment/immunology [MeSH], Ovarian Neoplasms/metabolism [MeSH], Ovarian Neoplasms/therapy [MeSH], Tumor Escape [MeSH], Immune interplay, Immunotherapy/methods [MeSH], Polysaccharides/immunology [MeSH], Immunotherapy, Review, Polysaccharides/metabolism [MeSH], Ovarian Neoplasms/etiology [MeSH], Humans, Animals, Female, Tumor Escape, Disease Susceptibility

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39432076
https://repository.publisso.de/resource/frl:6504687

Cystathionine‐gamma‐lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy

Autoren: Pierre Solomon Melanie Lancien Nahzli Dilek et al.

Weitere Verfasser: Pierre Solomon Melanie Lancien Nahzli Dilek et al.

Quelle: Cancer Sci
Cancer science, vol. 112, no. 5, pp. 1723-1734

Schlagwörter: 0301 basic medicine, MESH: Cystathionine gamma-Lyase / metabolism, [SDV]Life Sciences [q-bio], MESH: Extracellular Fluid / metabolism, CD8-Positive T-Lymphocytes, Inbred C57BL, Mice, MESH: Cell Engineering, Methionine, MESH: Glycine / metabolism, MESH: Methionine / metabolism, MESH: Models, Serine, Tumor Microenvironment, MESH: Animals, cysteine, Cell Engineering, Ovarian Neoplasms, 0303 health sciences, Tumor, MESH: Serine / metabolism, MESH: CD8-Positive T-Lymphocytes / metabolism, Adoptive Transfer, MESH: Ovarian Neoplasms / therapy, MESH: Proline / metabolism, Models, Animal, Female, amino acid, Proline, Glycine, MESH: Cysteine / biosynthesis, 03 medical and health sciences, MESH: Cell Proliferation, Cell Line, Tumor, Animals, MESH: Tumor Microenvironment / immunology, Cysteine, MESH: Mice, adoptive cell transfer, Cell Proliferation, Animal, Cystathionine gamma-Lyase, T cell, Extracellular Fluid, Original Articles, MESH: Cell Line, Mice, Inbred C57BL, Adoptive Transfer/methods, CD8-Positive T-Lymphocytes/metabolism, Cystathionine gamma-Lyase/metabolism, Cysteine/biosynthesis, Extracellular Fluid/metabolism, Glycine/metabolism, Methionine/metabolism, Ovarian Neoplasms/therapy, Proline/metabolism, Serine/metabolism, Tumor Microenvironment/immunology, metabolism, MESH: Adoptive Transfer / methods, MESH: Female

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33609296
https://pubmed.ncbi.nlm.nih.gov/33609296/
https://www.scilit.net/article/bedb2b3721ae12001b4ca52e8454ce18
https://onlinelibrary.wiley.com/doi/10.1111/cas.14862
https://www.ncbi.nlm.nih.gov/pubmed/33609296
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088958
https://europepmc.org/article/MED/33609296
https://serval.unil.ch/resource/serval:BIB_145E54BFE34D.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_145E54BFE34D2
https://serval.unil.ch/notice/serval:BIB_145E54BFE34D

Cancer worry is associated with increased use of supportive health care—results from the multinational InCHARGE study: results from the multinational InCHARGE study

Autoren: Jeppesen, M. M. Bergholdt, S. H. Bentzen, A. G. et al.

Quelle: Jeppesen, M M, Bergholdt, S H, Bentzen, A G, de Rooij, B H, Skorstad, M, Ezendam, N P M, van de Poll-Franse, L V, Vistad, I & Jensen, P T 2024, 'Cancer worry is associated with increased use of supportive health care—results from the multinational InCHARGE study', Journal of Cancer Survivorship, vol. 18, no. 1, pp. 165-175. https://doi.org/10.1007/s11764-023-01337-w

Schlagwörter: Ovarian Neoplasms, Gynecologic malignancy, Health care use, Ovarian Neoplasms/therapy, 3. Good health, Endometrial Neoplasms, 03 medical and health sciences, Cross-Sectional Studies, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Cancer Survivors, Surveys and Questionnaires, Humans, Female, Gynecologic cancer, Endometrial Neoplasms/therapy, Cancer worry, Delivery of Health Care

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36705796

Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise: a Delphi exercise

Autoren: Kathryn Baxter Heather Agnew Jennie Morgan et al.

Quelle: J Gynecol Oncol
Baxter, K, Agnew, H, Morgan, J, Holland, C, Flynn, D & Edmondson, R 2024, 'Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer : a Delphi exercise', Journal of gynecologic oncology, vol. 35, no. 5, e63. https://doi.org/10.3802/jgo.2024.35.e63

Schlagwörter: Ovarian Neoplasms, Consensus, Delphi Technique, Clinical Decision-Making, Patient Preference, Ovarian Neoplasms/therapy, Progression-Free Survival, United Kingdom, Decision Support Techniques, 3. Good health, Treatment Outcome, Surveys and Questionnaires, Humans, Original Article, Female

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38576342
http://www.scopus.com/inward/record.url?scp=85203852316&partnerID=8YFLogxK
https://doi.org/10.3802/jgo.2024.35.e63
https://research.manchester.ac.uk/en/publications/5aa08c1e-b475-47aa-88f3-a9173f2fcedb

Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancer

Autoren: Hyeong In, Ha Eun Young, Park Kyung Jin, Eoh et al.

Weitere Verfasser: Hyeong In, Ha Eun Young, Park Kyung Jin, Eoh et al.

Quelle: Gynecologic Oncology. 164:415-420

Schlagwörter: Adult, Fallopian Tube Neoplasms / genetics, Adolescent, Genes, BRCA2, Genes, BRCA1, BRCA1, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms / pathology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, 80 and over, Fallopian Tube Neoplasms / therapy, Fallopian Tube Neoplasms, Humans, Ovarian Neoplasms / genetics, Peritoneal Neoplasms / genetics, Peritoneal Neoplasms, Aged, Proportional Hazards Models, Aged, 80 and over, Ovarian Neoplasms, Ovarian Epithelial / genetics, Carcinoma, Ovarian cancer cluster region, Peritoneal Neoplasms / pathology, Middle Aged, Prognosis, BRCA2, Progression-Free Survival, 3. Good health, Survival Rate, Fallopian Tube Neoplasms / pathology, Genes, Peritoneal Neoplasms / therapy, Ovarian Epithelial / pathology, Ovarian Neoplasms / therapy, Female, Ovarian Epithelial / therapy

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34924242

Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels

Autoren: Undurraga Malinverno, Manuela Stefania Mathevet, Patrice Hubner, Martin et al.

Quelle: Revue Médicale Suisse. 18:990-996

Schlagwörter: Cytoreduction Surgical Procedures, Hyperthermia, Induced, Hyperthermic Intraperitoneal Chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Peritoneal Neoplasms / drug therapy, Antineoplastic Combined Chemotherapy Protocols, Humans, Ovarian Neoplasms / therapy, Female, Neoplasm Recurrence, Local / therapy, Carcinoma / therapy, Algorithms, Peritoneal Neoplasms / surgery

Dateibeschreibung: application/pdf

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer

Autoren: E Sun Paik Eun Jin Heo Chel Hun Choi et al.

Weitere Verfasser: E Sun Paik Eun Jin Heo Chel Hun Choi et al.

Quelle: Cancer Sci

Schlagwörter: Adult, overall survival, Mutation, Ovarian Epithelial / genetics, ovarian neoplasm, Carcinoma, Ovarian Epithelial, BRCA2 genes, Ovarian Neoplasms / pathology, 03 medical and health sciences, 0302 clinical medicine, Mutation Rate, Republic of Korea, Prevalence, Humans, BRCA2 Protein / genetics, Ovarian Neoplasms / genetics, Germ-Line Mutation, Republic of Korea / epidemiology, Aged, Retrospective Studies, BRCA2 Protein, Ovarian Neoplasms, BRCA1 Protein, Carcinoma, Original Articles, Middle Aged, Survival Analysis, Ovarian Epithelial / therapy, 3. Good health, Treatment Outcome, germline mutation, BRCA1 Protein / genetics, Ovarian Epithelial / pathology, BRCA1 genes, Ovarian Neoplasms / therapy, Female, Neoplasm Grading

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.15166
https://pubmed.ncbi.nlm.nih.gov/34657357
https://pubmed.ncbi.nlm.nih.gov/34657357/?fc=None&ff=20211018125431&v=2.15.0
https://onlinelibrary.wiley.com/doi/10.1111/cas.15166

Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee

Autoren: Kurtz, JE Gebski, V Sukhin, V et al.

Weitere Verfasser: Kurtz, JE Gebski, V Sukhin, V et al.

Quelle: Gynecologic Oncology. 161:502-507

Schlagwörter: Quality of life, Ovarian Neoplasms, Maintenance, Maintenance Chemotherapy, 3. Good health, PROMs, 03 medical and health sciences, 0302 clinical medicine, Ovarian cancer, Patient-Centered Care, Quality of Life, Ovarian Neoplasms / therapy, Randomized Controlled Trials as Topic / methods, Humans, Female, Ovarian Neoplasms / diagnosis, Patient Reported Outcome Measures, Patient-Centered Care / methods, Ovarian Neoplasms / drug therapy, Randomized Controlled Trials as Topic

Dateibeschreibung: text

Zugangs-URL: https://eprints.soton.ac.uk/448433/1/Incorporating_patient_centered_benefits_as_endpoints_in_randomized_trials_of_maintenance_therapies_in_advanced_ovarian_cancer.docx
https://pubmed.ncbi.nlm.nih.gov/33612336
https://pubmed.ncbi.nlm.nih.gov/33612336/
https://europepmc.org/article/MED/33612336
https://www.sciencedirect.com/science/article/abs/pii/S0090825821001554
https://www.ncbi.nlm.nih.gov/pubmed/33612336
https://www.gynecologiconcology-online.net/article/S0090-8258(21)00155-4/fulltext
https://discovery-pp.ucl.ac.uk/id/eprint/10124453/
https://eprints.soton.ac.uk/448433/

Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model.

Autoren: Sociali, G. Raffaghello, L. Magnone, M. et al.

Schlagwörter: 5'-Nucleotidase/antagonists & inhibitors, 5'-Nucleotidase/genetics, Acrylamides/pharmacology, Adenosine Triphosphate/analogs & derivatives, Adenosine Triphosphate/pharmacology, Animals, Cell Line, Tumor, Cytokines/antagonists & inhibitors, Female, GPI-Linked Proteins/antagonists & inhibitors, GPI-Linked Proteins/genetics, Humans, Mice, Nude, NAD/metabolism, Niacinamide/analogs & derivatives, Niacinamide/biosynthesis, Nicotinamide Mononucleotide/metabolism, Nicotinamide Phosphoribosyltransferase/antagonists & inhibitors, Ovarian Neoplasms/therapy, Piperidines/pharmacology, RNA Interference, RNA, Small Interfering/genetics

Dateibeschreibung: application/pdf

Relation: Oncotarget; https://iris.unil.ch/handle/iris/202207; serval:BIB_93788DFD2BBE

Verfügbarkeit: https://iris.unil.ch/handle/iris/202207
https://doi.org/10.18632/oncotarget.6502

Diagnostic histologique et pronostic des carcinomes ovariens, en particulier des carcinomes dits endométrioïdes [Histologic diagnosis and prognosis of ovarian carcinomas, in particular 'endometrioid' carcinomas]

Autoren: Genton, C. Hedinger, C.

Schlagwörter: Adenocarcinoma/classification, Adenocarcinoma/diagnosis, Adenocarcinoma/pathology, Biopsy, Carcinoma/classification, Cystadenocarcinoma/pathology, Endometriosis/classification, Endometriosis/diagnosis, Endometriosis/pathology, Female, Humans, Ovarian Neoplasms/classification, Ovarian Neoplasms/diagnosis, Ovarian Neoplasms/mortality, Ovarian Neoplasms/pathology, Ovarian Neoplasms/therapy, Prognosis

Relation: Schweizerische medizinische Wochenschrift; https://iris.unil.ch/handle/iris/183681; serval:BIB_9E57735D78CA; A1970H904000004; 5525044

Verfügbarkeit: https://iris.unil.ch/handle/iris/183681

Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy.

Autoren: Goldhirsch, A. Greiner, R. Dreher, E. et al.

Schlagwörter: Abdomen, Adult, Aged, Altretamine/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cisplatin/administration & dosage, Clinical Trials as Topic, Combined Modality Therapy, Female, Humans, Melphalan/administration & dosage, Middle Aged, Ovarian Neoplasms/radiotherapy, Ovarian Neoplasms/therapy, Radiotherapy/methods

Relation: Cancer; https://iris.unil.ch/handle/iris/112073; serval:BIB_5A16A72E84C3; A1988N986500009; 3133102

Verfügbarkeit: https://iris.unil.ch/handle/iris/112073

Genomic profiling of the residual disease of advanced high‐grade serous ovarian cancer after neoadjuvant chemotherapy

Autoren: Yong J. Lee Dachan Kim Jung E. Shim et al.

Weitere Verfasser: Yong J. Lee Dachan Kim Jung E. Shim et al.

Quelle: International Journal of Cancer. 146:1851-1861

Schlagwörter: Neoplasm, Residual, Biopsy, Drug Resistance, TOR Serine-Threonine Kinases/metabolism, Ovarian Neoplasms/therapy, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Signal Transduction/drug effects, Serous/therapy, Antineoplastic Combined Chemotherapy Protocols, Proto-Oncogene Proteins c-akt/metabolism, Ovarian Neoplasms, Cell Cycle, Cytoreduction Surgical Procedures, Genomics, Middle Aged, Progression-Free Survival, Neoadjuvant Therapy, 3. Good health, Ovariectomy/methods, ovarian cancer, Residual, Disease Progression, Female, Phosphatidylinositol 3-Kinases/metabolism, genomic profiling, Ovarian Neoplasms/mortality, Ovary/pathology, Adult, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Ovarian Neoplasms/genetics, Ovariectomy, Cystadenocarcinoma, Ovary/drug effects, Mutation/drug effects, 03 medical and health sciences, Humans, Cell Cycle/genetics, Serous/genetics, Retrospective Studies, Aged, Neoplasm/genetics, Neoadjuvant Therapy/methods, Ovary, Survival Analysis, Cystadenocarcinoma, Serous, Serous/mortality, Drug Resistance, Neoplasm, high-grade serous carcinoma, Mutation, residual disease, Neoplasm, Signal Transduction/genetics, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cytoreduction Surgical Procedures/methods

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31603993
https://ir.ymlib.yonsei.ac.kr/handle/22282913/175482
https://onlinelibrary.wiley.com/doi/10.1002/ijc.32729
https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.32729
https://www.ncbi.nlm.nih.gov/pubmed/31603993
https://pubmed.ncbi.nlm.nih.gov/31603993/

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Autoren: Ray-Coquard, Isabelle Cibula, David Mirza, Mansoor R et al.

Weitere Verfasser: Ray-Coquard, Isabelle Cibula, David Mirza, Mansoor R et al.

Quelle: International Journal of Cancer, 146, 2, pp. 439-448

Schlagwörter: Cancer Research, Indoles, Oncologie, Ovarian Neoplasms/therapy, Carboplatin, Placebos, tyrosine kinase inhibitor, 0302 clinical medicine, Ovarian Neoplasms/pathology, Antineoplastic Combined Chemotherapy Protocols, Paclitaxel/adverse effects, nintedanib, Human health sciences, Medical Oncology - Radboud University Medical Center, Aged, 80 and over, Ovarian Neoplasms, Indoles/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Progression-Free Survival, 3. Good health, ovarian cancer, Oncology, Chemotherapy, Adjuvant, Indoles/adverse effects, Female, Chemotherapy, Adjuvant/methods, Ovarian Neoplasms/mortality, Adult, Paclitaxel, overall survival, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Protein Kinase Inhibitors/adverse effects, Sciences de la santé humaine, Young Adult, 03 medical and health sciences, Carboplatin/adverse effects, Chemotherapy, Adjuvant/adverse effects, Paclitaxel/administration & dosage, Ovary/surgery, Humans, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Protein Kinase Inhibitors/administration & dosage, Ovary, Carboplatin/administration & dosage, antiangiogenic, anti-angiogenic, Ovary/pathology, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31381147
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/218867
https://doi.org/10.1002/ijc.32606
https://publicatt.unicatt.it/handle/10807/141114
https://boa.unimib.it/handle/10281/241889
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902219141510847
https://moh-it.pure.elsevier.com/en/publications/final-results-from-gcigengotago-ovar-12-a-randomised-placebo-cont
https://www.ncbi.nlm.nih.gov/pubmed/31381147
https://europepmc.org/article/MED/31381147
https://hdl.handle.net/2066/218867
https://repository.ubn.ru.nl//bitstream/handle/2066/218867/218867.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32606
https://doi.org/10.1002/ijc.32606
https://hdl.handle.net/10281/241889
https://hdl.handle.net/2268/309155
https://doi.org/10.1002/ijc.32606
https://hdl.handle.net/10807/141114
https://doi.org/10.1002/ijc.32606

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy

Autoren: Young Shin Chung Sang Wun Kim Sunghoon Kim et al.

Weitere Verfasser: Young Shin Chung Sang Wun Kim Sunghoon Kim et al.

Quelle: European Journal of Surgical Oncology. 45:644-649

Schlagwörter: Adult, Carcinoma, Ovarian Epithelial, Interval debulking surgery, Ovarian Epithelial/therapy, 03 medical and health sciences, 0302 clinical medicine, Ovarian Neoplasms/pathology, Ovarian cancer, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Chemotherapy, Humans, Ovarian Neoplasms/blood, Ovarian Epithelial/secondary, CA-125, Adjuvant, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Ovarian Neoplasms, Ovarian Neoplasms/therapy, Carcinoma, Ovarian Epithelial/blood, Cytoreduction Surgical Procedures, Middle Aged, CA-125 Antigen/blood, Prognosis, Neoadjuvant Therapy, Progression-Free Survival, 3. Good health, Survival Rate, Chemotherapy, Adjuvant, CA-125 Antigen, Preoperative Period, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/30337203
https://pubmed.ncbi.nlm.nih.gov/30337203/
https://yonsei.pure.elsevier.com/en/publications/prognostic-significance-of-ca-125-re-elevation-after-interval-deb
https://ir.ymlib.yonsei.ac.kr/handle/22282913/173413
https://www.sciencedirect.com/science/article/pii/S0748798318314537
https://www.ncbi.nlm.nih.gov/pubmed/30337203

Tératome ovarien chez l’enfant. Revue de la littérature à propos d’un cas clinique. ; Ovarian teratoma in children. Clinical case and review of the literature.

Autoren: Rousseau, Marie-Cécile Demarche, M Dresse, Marie-Françoise et al.

Quelle: Revue Médicale de Liège, 77 (1), 39-44 (2022-01)

Schlagwörter: Immature Teratoma, Mature Teratoma, Ovarian Teratoma, Child, Humans, Ovarian Neoplasms/diagnosis, Ovarian Neoplasms/therapy, Teratoma/diagnosis, Teratoma/therapy, Ovarian Neoplasms, Teratoma, Medicine (all), Human health sciences, Pediatrics, Oncology, Surgery, Sciences de la santé humaine, Pédiatrie, Oncologie, Chirurgie

Relation: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/299294; info:hdl:2268/299294; https://orbi.uliege.be/bitstream/2268/299294/1/T%c3%a9ratome%20ovarien%20chez%20l%27enfant.pdf; info:pmid:35029339

Verfügbarkeit: https://orbi.uliege.be/handle/2268/299294
https://orbi.uliege.be/bitstream/2268/299294/1/T%c3%a9ratome%20ovarien%20chez%20l%27enfant.pdf

Prise en charge initiale actuelle des ­carcinomes ovariens séreux de haut grade avancés [Current management of advanced high grade serous ovarian carcinomas]

Autoren: Durand, Y. Nicod Lalonde, M. Hastir, D. et al.

Quelle: Revue medicale suisse, vol. 20, no. 891, pp. 1848-1854

Schlagwörter: Humans, Female, Ovarian Neoplasms/therapy, Ovarian Neoplasms/diagnosis, Ovarian Neoplasms/pathology, Cystadenocarcinoma, Serous/therapy, Cystadenocarcinoma, Serous/diagnosis, Cystadenocarcinoma, Serous/pathology, Prognosis, Neoplasm Grading

Dateibeschreibung: application/pdf

Zugangs-URL: https://serval.unil.ch/resource/serval:BIB_33A75F2F4F0F.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_33A75F2F4F0F
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_33A75F2F4F0F1

Tératome ovarien chez l’enfant. Revue de la littérature à propos d’un cas clinique.
Ovarian teratoma in children. Clinical case and review of the literature.

Autoren: Rousseau, Marie-Cécile Demarche, M Dresse, Marie-Françoise et al.

Quelle: Revue Médicale de Liège, 77 (1), 39-44 (2022-01)

Schlagwörter: Immature Teratoma, Mature Teratoma, Ovarian Teratoma, Child, Humans, Ovarian Neoplasms/diagnosis, Ovarian Neoplasms/therapy, Teratoma/diagnosis, Teratoma/therapy, Ovarian Neoplasms, Teratoma, Medicine (all), Human health sciences, Pediatrics, Oncology, Surgery, Sciences de la santé humaine, Pédiatrie, Oncologie, Chirurgie

Relation: urn:issn:0370-629X; urn:issn:2566-1566

Zugangs-URL: https://orbi.uliege.be/handle/2268/299294